Quarterly report pursuant to Section 13 or 15(d)

Condensed Statement of Cash Flows (Unaudited)

Condensed Statement of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2018
Dec. 31, 2017
Operating Activities    
Net loss $ 21,980 $ (123,948)
Adjustments to reconcile net loss to net cash used in operating activities:    
Interest earned on marketable securities held in Trust Account   (554,326)
Change in operating assets and liabilities:    
Receivable from related party   (93,098)
Prepaid expenses   (144,789)
Accounts payable   54,474
Other current liabilities   171,827
Net cash used in operating activities   (689,860)
Investing Activities    
Investment of cash in Trust Account, net   (143,750,000)
Net cash used in investing activities   (143,750,000)
Financing Activities    
Proceeds from sale of Units, net of underwriting discounts paid   141,162,440
Proceeds from sale of Private Placement Units   4,982,560
Proceeds from the sale of Founder Shares   25,000
Promissory notes from related parties   50,536
Repayment of promissory notes from related parties   (50,536)
Payment of deferred offering costs   (579,498)
Net cash provided by financing activities   145,590,502
Net change in cash and cash equivalents   1,150,642
Cash and cash equivalents, beginning of period $ 1,150,642  
Cash and cash equivalents, end of period   $ 1,150,642